American Society of Clinical Oncology

SHERPA: White

People

  1. Ginsberg
    Ginsberg
  2. Pandit-Taskar
    Pandit-Taskar
  3. Pfister
    Pfister
  4. Schwartz
    Schwartz
  5. Stambuk
    Stambuk
  6. Feldman
    Feldman
  7. Kris
    Kris
  8. Motzer
    Motzer
  9. Riely
    Riely
  10. Sherman
    Sherman

Groups

  1. Radiology, Department of (23)
  2. Department of Medicine (21)
  3. Solid Tumor Oncology Division (18)
  4. Biostatistics Service (12)
  5. Body Imaging Service (12)
  6. Epidemiology and Biostatistics (12)
  7. GSK Faculty (8)
  8. Genitourinary Oncology Service (7)
  9. Hematologic Malignancies, Division of (6)
  10. Molecular Imaging and Therapy Service (6)
Search Within
  1. "2009"
  2. "Radiology, Department of"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (8)
Groups
  1. Radiology, Department of (23)
  2. Department of Medicine (21)
  3. Solid Tumor Oncology Division (18)
  4. Biostatistics Service (12)
  5. Body Imaging Service (12)
  6. Epidemiology and Biostatistics (12)

More Groups

People
  1. David Pfister (4)
  2. Hilda Stambuk (4)
  3. Lawrence Schwartz (4)
  4. Matthew Fury (4)
  5. Michelle Ginsberg (4)
  6. Neeta Pandit-Taskar (4)

More People

Years
  1. 2009 (23)
Publications
  1. Journal of Clinical Oncology (23)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of depsipeptide (DEP) in radioiodine (RAI)-refractory metastatic nonmedullary thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Fury, M. G.; Tuttle, R. M.; Ghossein, R.; Stambuk, H.; Baum, M.; Lisa, D.; Su, Y. B.; Shaha, A.; Pfister, D. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results
    Meeting Abstract

    Pfister, D. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Carlson, D.; Stambuk, H.; Shen, R.; Kraus, D.; Shah, J.; Fury, M. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I/II study of arginine deiminase (ADI-PEG 20) in patients with advanced malignant melanoma (MM)
    Meeting Abstract

    Ott, P. A.; Carvajal, R. D.; Pandit-Taskar, N.; Jungbluth, A. A.; Hoffman, E.; Venhaus, R.; Pan, L.; Old, L.; Pavlick, A. C.; Wolchok, J. D.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
    Meeting Abstract

    Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Rathkopf, D.; Solit, D.; Carrasquillo, J.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Treatment outcome and survival for patients (pts) with sarcomatoid-variant metastatic renal cell carcinoma (RCC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Molina, A. M.; Tickoo, S. K.; Ishill, N.; Trinos, M. J.; Schwartz, L. H.; Russo, P.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with (18)f-fluoromisonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases
    Meeting Abstract

    Lee, N.; Jensen, J.; Schoder, H.; Wang, Y.; Fury, M.; Pfister, D. G.; Stambuk, H.; Humm, J.; Koutcher, J.; Shukla-Dave, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Kroog, G. S.; Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Ishill, N. M.; Motzer, R. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced stage epithelial ovarian cancer
    Meeting Abstract

    Kolev, V.; Mironov, S.; Mironov, O.; Moskowitz, C.; Ishill, N. M.; Gardner, G. J.; Levine, D. A.; Hricak, H.; Barakat, R. R.; Chi, D. S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save